期刊文献+

纳米粒子作为药物输送和药物控释体系的应用前景 被引量:1

Perspective on the application of nanoparticules as drug delivery and control release systems
下载PDF
导出
摘要 纳米粒子作为药物和基因的载体显现出极大的潜力并被广泛研究。纳米粒子的超微小体积可使药物输送智能化,例如靶向定位地将药物投递到病灶局部或专一性地作用于靶细胞。纳米粒子的载体材料可屏蔽药物不良气味、维持药物长期缓慢释放、延长药物半衰期和减小毒副作用等。本文将从纳米药物输送、控释制剂的制备和应用前景等方面进行综述。 Nanoparticule (NP) as a drug and gene carrier has shown great potential and has been widely studied. Due to its ultra-small size, NP can achieve intelligent delivery of drugs, such as deliver drug site-speclficaLly to disease focus or targeted tissue, even into target cells. The carrier materials of NPs provide it with such advantages as shielding odor, long-term sustained releasing of drug, lowering toxicity, extend biologic half life of drug and gene, etc. This review emphasizes the manufacturing techniques and application of nanoparticles as drug and gene delivery system.
作者 杨菁 宋存先
出处 《基础医学与临床》 CSCD 北大核心 2006年第7期684-688,共5页 Basic and Clinical Medicine
基金 国家自然科学基金(50473059) 天津市应用基础重点项目(043803011) 博士学科点专项基金(20030023004) 天津市自然科学基金(05YFJMJC10100)
关键词 纳米粒子 药物载体 基因载体 控制释放 nanoparticles drug delivery gene delivery controlled release
  • 相关文献

参考文献25

  • 1Muller RH,Jacobs C,Kayser O.Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future[J].Advanced Drug Delivery Reviews,2001,47:3-19.
  • 2Allemann E,Gury R,Doelker E.Drug-loaded nanoparti cles preparation methods and drug targeting issue[J].Eur J Pharm Biopharm,1993,39(5):173.
  • 3Kreuter J.Nanoparticles and microparticles for drug and vaccine delivery[J].J Anat,1996,189:503.
  • 4Song CX,Labhaseetwar V,Murphy H,et al.Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery[J].J Control Rel,1997,43:197 -212.
  • 5Convreur P,Duberner C,Puisieux F.Controlled drug deliv ery with nanoparticles:current possibilities and future trends[J].Eur J Pharm Biopharm,1995,41(1):21.
  • 6Scholes PD,Coombes AG,Lllum L,et al.The preparation of sub-200 nm poly (lactide-co-glycolide) micro-spheres for site-specific drug delivery[J].Control Rel,1993,25:145-153.
  • 7Yoshiaka K,Hiromistu Y.Properties of a pepfide containing DL-lactide/glycolide copolymer nanosphere by novel emulsion solvent difusion method[J].Eur J Pharmaceufics Biopharmaceutics,1998,45:41 -48.
  • 8Coska I,Eros I.Stability of multiple emulsions.Determination of factors influenceing multiple drop breakdown[J].Inter J Pharmaceufics,1997,156:119-123.
  • 9Thiruma G,Snjezata S.PLGA nanoparticles preparation by nanoprecipitation:drug loading an d release studies of a water solution drug[J].J Controll Release,1999,57:171 -185.
  • 10Hideki M,Masao K.Further application of a modified spontaneous emulsification solvent difusion method to various types of PLGA and PLA polymers for preparation of nanoparticles[J].Powder Technol,2000,107:137-143.

二级参考文献33

  • 1张志荣,廖工铁.聚氰基丙烯酸酯毫微球的研究进展[J].中国药学杂志,1994,29(6):323-326. 被引量:13
  • 2Liu Y, Bacon ER, Ballinger K, et al. Pharmacokinetics and hepatic disposition of bis[(1-cethoxycarbonyl)propyl] 5-acetylamino-2,4,6-triiodoisophthalate in rats and isolated perfused rat livers. Drug Metab Dispos, 2000, 7:731-736.
  • 3Nolte-Ernsting C, Adum G, Bucker A, et al. Abdominal MR angiography performed using blood pool contrast agents: comparison of a new superparamagnetic iron oxide nanoparticle and a lineargadolinium polymer. Am J Roentgenol, 1998, 171:107-113.
  • 4Wunderbaldinger P, Josephson L, Weissleder R. Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem, 2002,2:284-268.
  • 5Soma CE, Dubernet C, Barratt G, et al. Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 Cells in vitro. J Control Release, 2000,2:283-289.
  • 6Zimmer A. Antisense oligonucleotide delivery with polyhexylcyanoacrylate nanoparticles as carriers. Methods,1999,3:286-295.
  • 7Hood JD, Bednarski M, Fransto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science, 2002,28:2404-2407.
  • 8Eliceiri BP,klemke R, Stromblad S, et al. Integrin alpha v beta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol, 1998,140:1255-1263.
  • 9Brooks PC, Montgomery AM, Rosenfeld M, et al. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 1994,79:1157-1164.
  • 10Mintorovitch J, Shamsi K. Eovist injection two new liver-specific contrast agents for MRI. Oncology, 2000,14: 37-46.

共引文献16

同被引文献6

  • 1Chen Chaomei. Searching for intellectual turning points : Progressive knowledge domain visualization//Proceedings of the National Academy of Sciences of the United States of America,2004,101 ( Suppl. 1 ) :5303 -5301.
  • 2陈悦,侯海燕,刘则渊.科学知识图谱:方法与应用.北京:人民出版社,2008.
  • 3Scheller F W, Bier F F, Pfeiffer D 1. Biosensors-principles and applications. Teehnisches Messen, 1995,62(5) : 213 -219.
  • 42.2. RI Webstart 版本 [2009 -06 - 16]. http://cluster, cis. drexel, edu/- ccherr/CiteSpace/.
  • 5碳纳米管.[2009-06-16].http://baike.baidu.com/view/2485.htm.
  • 6齐艳霞,刘则渊,赵玉鹏,侯剑华.信息可视化视野下的工程伦理前沿研究[J].伦理学研究,2008(5):49-54. 被引量:5

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部